Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.60
Bid: 18.60
Ask: 18.98
Change: -0.07 (-0.37%)
Spread: 0.38 (2.043%)
Open: 20.00
High: 20.00
Low: 18.60
Prev. Close: 18.86
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update and Notice of Results

15 Aug 2018 07:00

RNS Number : 8174X
Nanoco Group PLC
15 August 2018
 

15 August 2018

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Year End Trading Update

 

Notice of Results

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nano-materials, today provides the following year end trading update ahead of the announcement of its final results for the year to 31 July 2018, which will be released on 16 October 2018.

 

Highlights of the year include:

 

· Nano-materials:

o Steady progress has been made in the execution of the Material Development and Supply Agreements, announced in February and April 2018 with a large, undisclosed US listed corporation ('the Partner').

 

o The new manufacturing facilities in Runcorn are progressing as planned. Small-scale commercial shipments are expected to commence in calendar Quarter 4, 2018 and volume production is expected to commence in the second half of calendar 2019. H1 2019 calendar year will be utilised to stress test and improve the new Runcorn facility.

 

· Display:

o Nanoco continues to make progress in display, initially with gaming monitors. Nanoco's patented CFQD resin is being provided to Wah Hong to convert into film for a Taiwanese display panel maker. These gaming monitors are on track to launch to the public for the 2018 end of year holiday season.

 

· Financial:

o The Company's unaudited cash position at 31 July 2018 has increased by £2.0m to £10.7m since 31 January 2018 (31 January 2018: £8.7m; 31 July 2017: £5.7m).

 

o Unaudited revenues for the year ended 31 July 2018 of up to £2.5m arising from the first agreement with the Partner based on management's assessment that the project will be complete by 31 December 2018. This assessment will be confirmed prior to the release of the Preliminary Results and revenue will be adjusted accordingly if required. Revenues from other agreements and sales during the year amounted to c. £0.8m. As a result, unaudited revenues are expected to be up to £3.3m (31st July 2017 £1.3m).

 

o £8m net proceeds from November 2017 fundraise.

 

 

Executive team reorganisation

 

During the period, Nanoco successfully implemented a structured reorganisation of its executive team, combining its Chief Financial Officer and Chief Operating Officer positions into one unified role, and appointing Brian Tenner to this new position, effective from 20 August 2018. Current Chief Financial Officer David Blain will step down from his position on 20 August, and will remain with Nanoco until 15 October 2018 to facilitate an orderly handover of his duties.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"The second half of 2018 has been transformational for Nanoco with the signing of the development and supply agreement with our large US-listed partner in our nano-materials division. We have made meaningful progress in display and lighting with first commercial products expected later this calendar year. Our cash position has improved since last reporting and we start the new financial year with considerable confidence."

 

- Ends -

 

 

For further information, please contact:

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Chris Richards, Non-Executive Chairman

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

The information contained within this announcement constitutes inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUSRARWAAWAUR
Date   Source Headline
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return
5th Jun 20204:41 pmRNSSecond Price Monitoring Extn
5th Jun 20204:35 pmRNSPrice Monitoring Extension
28th May 20207:00 amRNSQuantum Dot Material Supply Agreement
30th Apr 202012:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
30th Apr 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.